0000899243-19-010813.txt : 20190417 0000899243-19-010813.hdr.sgml : 20190417 20190417184122 ACCESSION NUMBER: 0000899243-19-010813 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190415 FILED AS OF DATE: 20190417 DATE AS OF CHANGE: 20190417 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Aivado Manuel CENTRAL INDEX KEY: 0001709603 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38130 FILM NUMBER: 19754030 MAIL ADDRESS: STREET 1: C/O AILERON THERAPEUTICS, INC. STREET 2: 281 ALBANY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC CENTRAL INDEX KEY: 0001420565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 ARSENAL WAY CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-995-0900 MAIL ADDRESS: STREET 1: 490 ARSENAL WAY CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-04-15 0 0001420565 AILERON THERAPEUTICS INC ALRN 0001709603 Aivado Manuel C/O AILERON THERAPEUTICS, INC. 490 ARSENAL WAY WATERTOWN MA 02472 1 1 0 0 President and CEO Stock Option (right to buy) 1.75 2019-04-15 4 A 0 500000 0.00 A 2029-04-14 Common Stock 500000 500000 D This option was granted on April 15, 2019. The shares underlying the option are scheduled to vest in equal monthly installments over four years from April 15, 2019. /s/ Donald Dougherty, attorney-in-fact for Manuel Aivado 2019-04-17